Company: ZLAB
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001628280-25-020478
Chunk: 10

Company: Zai Lab Ltd
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 10
---
 Johnson company) (2003-2008), including Senior Vice President of New Product Development and Business Development

• Various roles of increasing responsibility at Millennium Pharmaceuticals, Inc. (previously COR Therapeutics, Inc.) in sales, marketing, medical affairs, and business development (1998-2003)

• B.S. from the University of Maryland

#### Scott William Morrison
Independent Director

| Age                                   |     |                   Director Since |     | Board Committees       |     | Other Public Company Boards           |
| 67                                    |     |                             2021 |     | Audit, Chair and Audit |     | Corvus Pharmaceuticals, Inc. (NASDAQ) |
| Committee Financial Expert            |     | IDEAYA Biosciences Inc. (NASDAQ) |     |                        |     |                                       |
| Tarsus Pharmaceuticals, Inc. (NASDAQ) |     |                                  |     |                        |     |                                       |
| Vera Therapeutics, Inc. (NASDAQ)      |     |                                  |     |                        |     |                                       |

Mr. Morrison brings to the Board of Directors financial expertise obtained from his extensive business, accounting, and financial background obtained from his over 35 years of experience serving public and private companies in the life sciences industry until his retirement in 2015 as well as his significant board and audit committee experience.

#### Key Experience and Qualifications
• Partner with Ernst & Young LLP (1996-2015), serving as U.S. Life Sciences Leader from 2002 to 2015

• Member of the Board of Directors, Chairperson of the Audit Committee, and Member of the Compensation Committee of Corvus Pharmaceuticals, Inc. (2015-Present)

• Member of the Board of Directors, Chair of the Audit Committee, and Member of the Nominating and Corporate Governance Committee of IDEAYA Biosciences Inc. (July 2018-Present)

• Member of the Board of Directors, Chair of the Audit Committee, and Member of the Commercial Committee of Vera Therapeutics, Inc. (April 2020-Present)

• Member of the Board of Directors, Chair of the Audit Committee, and Member of the Commercial Committee of Tarsus Pharmaceuticals, Inc. (October 2022-Present)

• Member of the Board of Directors, Chair of the Audit Committee, Chair of the Transaction and Financing Committee, and Member of the Compensation Committee and Commercial Committee of Global Blood Therapeutics, Inc. (NASDAQ) (2016-its acquisition by Pfizer Inc. in October